SCHEMBL19126753

SCHEMBL19126753

CC(C)(C)OC(=O)N1CCN(C(=O)Cc2ccc(-n3cc(CC(=O)O)nn3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 6/20 0.52
▸ GRM1 Q13255 3/20 0.48
▸ GRM5 P41594 2/20 0.48
▸ HTT P42858 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ KDM1A O60341 5/20 0.45
▸ TUBB4A P04350 1/20 0.44
▸ TUBB P07437 1/20 0.44
▸ TUBA3C P0DPH7 1/20 0.44
▸ TUBA1B P68363 1/20 0.44
▸ TUBA4A P68366 1/20 0.44
▸ TUBB4B P68371 1/20 0.44
▸ TUBB3 Q13509 1/20 0.44
▸ TUBB2A Q13885 1/20 0.44
▸ TUBB8 Q3ZCM7 1/20 0.44
▸ TUBA3E Q6PEY2 1/20 0.44
▸ TUBA1A Q71U36 1/20 0.44
▸ KDM1B Q8NB78 1/20 0.44
▸ TUBA1C Q9BQE3 1/20 0.44
▸ TUBB6 Q9BUF5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19127388 0.88 GPR119 (0.54) GPR119GRM1GRM5HTTATM
SCHEMBL19126500 0.87 GPR119 (0.49) GPR119GRM1GRM5HTTATM
SCHEMBL19126721 0.86 GPR119 (0.58) GPR119GRM1GRM5HTTATM
SCHEMBL19126554 0.84 GPR119 (0.51) GPR119GRM1GRM5HTTATM
SCHEMBL19146302 0.84 GPR119 (0.50) GPR119GRM1GRM5HTTATM
SCHEMBL20676167 0.83 GPR119 (0.58) GPR119GRM1GRM5CA12CA1
SCHEMBL16770278 0.82 GPR119 (0.60) GPR119
SCHEMBL19126818 0.82 GPR119 (0.48) GPR119GRM1GRM5HTTATM
SCHEMBL19126575 0.81 GPR119 (0.48) GPR119GRM1GRM5HTTATM
SCHEMBL19145401 0.81 GPR119 (0.49) GPR119GRM1GRM5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939314-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2024-03-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
EP-3402792-A1 QUINOLIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-11-21 — — EP disclosed
WO-2017121444-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2017-07-20 — — WO disclosed
WO-2017121444-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2017-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174241-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 GPR119 1948/4885GRM1 2527/4885GRM5 4225/4885
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 GPR119 1948/4885GRM1 2527/4885GRM5 4225/4885
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 GPR119 1948/4885GRM1 2527/4885GRM5 4225/4885
US-11939314-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 GPR119 1948/4885GRM1 2527/4885GRM5 4225/4885
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 GPR119 1948/4885GRM1 2527/4885GRM5 4225/4885
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 GPR119 1948/4885GRM1 2527/4885GRM5 4225/4885
US-10669251-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 GPR119 1948/4885GRM1 2527/4885GRM5 4225/4885
US-11186562-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 GPR119 1948/4885GRM1 2527/4885GRM5 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback